Recent Finacing
Recent Raise
Aura Biosciences develops a virus-like drug conjugate (VDC) platform producing light-activated viral nanoparticle therapeutics—lead AU-011 targets ocular melanoma via ophthalmic laser activation for office-based, non-surgical delivery.
